Company: DGLY
Filing Date: 2025-06-27
Form Type: 424B4
Source: 0001641172-25-016976
Chunk: 3

Company: DIGITAL ALLY, INC.
Filing Date: 2025-06-27
Form: 424B4
Chunk 3
---
The Warrants are exercisable only upon notice of receipt of such stockholder approval (the “Warrant Stockholder Approval”) to approve each of (i) certain terms in the Warrants and the issuance of the shares of common stock issuable upon the exercise of such Warrants, as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC, which was approved at a special meeting of stockholders of the Company held on May 6, 2025 (the “Special Meeting”), and (ii) if necessary, a proposal to amend the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), to increase the authorized share capital of the Company to an amount sufficient to cover the shares of common stock issuable upon the exercise of the Warrants, which was not approved at the Special Meeting.

Our common stock is listed on The Nasdaq Capital Market under the symbol “DGLY.” There is no established trading market for the Warrants and we do not intend to list the Warrants on any securities exchange or nationally recognized trading system.

We engaged Aegis Capital Corp. (“Aegis” or the “underwriter”) to act as our exclusive underwriter on a firm commitment basis in connection with the Offering. We have agreed to pay to the underwriter the underwriting fees as set forth in the table below. We will bear all costs associated with the offering. See “ Underwriting” on page 32 of this prospectus for more information regarding these arrangements.

We granted the underwriter an option to purchase
additional shares of common stock and/or Warrants of (i) up to 15% of the number of shares of common stock sold in the Offering,
(ii) up to 15% of the number of Series A Warrants sold in the Offering and (iii) up to 15% of the number of Series B Warrants
sold in the Offering. On February 14, 2025, the underwriter exercised its over-allotment option with respect to 7,500 Series
A Warrants and 7,500 Series B Warrants.

Thepublic offering price used throughout this prospectus is indicative of the final offering price. The final public offering price was determined through negotiation between us and the underwriter based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of the Offering.